Bone marrow cells: The source of hepatocellular carcinoma?

Medical Hypotheses

Volumn 69, Issue 1, 2007, Pages 36-42

  Wu, Xiong Zhi ^a   Yu, Xiao Hui ^b  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b LANZHOU GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR;

ARTICLE; BONE MARROW CELL; CANCER STEM CELL; CARCINOGENESIS; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CHRONIC DISEASE; CHRONIC INFLAMMATION; CORRELATION ANALYSIS; EXTRACELLULAR MATRIX; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; LIVER CELL; LIVER CELL CARCINOMA; LIVER DEVELOPMENT; LIVER INJURY; LIVER REGENERATION; PRIORITY JOURNAL; STOMACH CANCER;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; HEMATOPOIETIC STEM CELLS; HUMANS; LIVER NEOPLASMS; MODELS, BIOLOGICAL;

EID: 34247855852     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2006.10.064     Document Type: Article

References (105)

1. Lapidot T., Sirard C., Vormoor J., Murdoch B., Hoang T.C.-C.J., Minden M., et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367 (1994) 645-648
2. George A.A., Franklin J., Kerkof K., Shah A.J., Price M., Tsark E., et al. Detection of leukemic cells in the CD34(-)CD38(-) bone marrow progenitor population in children with acute lymphoblastic leukemia. Blood 97 (2001) 3925-3930
3. Nilsson L., Astrand-Grundstrom I., Anderson K., Arvidsson I., Hokland P., Bryder D., et al. Involvement and functional impairment of the CD34(-)CD38(-)Thy-1(-) hematopoietic stem cell pool in myelodysplastic syndromes with trisomy 8. Blood 100 (2002) 259-267
4. Al Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., and Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100 (2003) 3983-3988
5. Matsui W.H., Huff C.A., Wang Q., Malehorn M.T., Barber J., Tanhehco Y., et al. Characterization of clonogenic multiple myeloma cells. Blood 103 (2004) 2332-2336
6. Fomchenko E.I., and Holland E.C. Stem cells and brain cancer. Exp Cell Res 306 (2005) 323-329
7. Reya T., Morrison S.J., Clarke M.F., and Weissman I.L. Stem cells, cancer, and cancer stem cells. Nature 414 (2001) 105-111
8. Pardal R., Clarke M.F., and Morrison S.J. Applying the principles of stem-cell biology to cancer. Nat Rev Cancer 3 (2003) 895-902
9. Rubio D., Garcia-Castro J., Marti{dotless}́n M.C., de la Fuente R., Cigudosa J.C., Lloyd A.C., et al. Spontaneous human adult stem cell transformation. Cancer Res 65 (2005) 3035-3039
10. Burns J.S., Abdallah B.M., Guldberg P., Rygaard J., Schrøder H.D., and Kassem M. Tumorigenic heterogeneity in cancer stem cells evolved from long-term cultures of telomerase-immortalized human mesenchymal stem cells. Cancer Res 65 (2005) 3126-3135
11. Serakinci N., Guldberg P., Burns J.S., Abdallah B., Schrodder H., Jensen T., et al. Adult human mesenchymal stem cell as a target for neoplastic transformation. Oncogene 23 (2004) 5095-5098
12. Houghton J., Stoicov C., Nomura S., Rogers A.B., Carlson J., Li H., et al. Gastric cancer originating from bone marrow-derived cells. Science 306 (2004) 1568-1571
13. Theise N.D., Badve S., Saxena R., Henegariu O., Sell S., Crawford J.M., et al. Derivation of hepatocytes from bone marrow cells in mice after radiation-induced myeloablation. Hepatology 31 (2000) 235-240
14. Krause D.S., Theise N.D., Collector M.I., Henegariu O., Hwang S., Gardner R., et al. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 105 (2001) 369-377
15. Petersen B.E., Goff J.P., Greenberger J.S., and Michalopoulos G.K. Hepatic oval cells express the hematopoietic stem cell marker Thy-1 in the rat. Hepatology 27 (1998) 433-445
16. Baumann U., Crosby H.A., Ramani P., Kelly D.A., and Strain A.J. Expression of the stem cell factor receptor c-kit in normal and diseased pediatric liver: identification of a human hepatic progenitor cell. Hepatology 30 (1999) 112-117
17. Lemmer E.R., Shepard E.G., Blakolmer K., Kirsch R.E., and Robson S.C. Isolation from human fetal liver of cells co-expressing CD34 haematopoietic stem cell and CAM 5.2 pancytokeratin markers. J Hepatol 29 (1998) 450-454
18. Petersen B.E., Grossbard B., Hatch H., Pi L., Deng J., and Scott E.W. Mouse A6-positive hepatic oval cells also express several hematopoietic stem cell markers. Hepatology 37 (2003) 632-640
19. Petersen B.E., Bowen W.C., Patrene K.D., Mars W.M., Sullivan A.K., Murase N., et al. Bone marrow as a potential source of hepatic oval cells. Science 284 (1999) 1168-1170
20. Ptersen B.E. Hepatic "stem" cells: coming full circle b1ood cells. Mol Dis 27 (2001) 590-600
21. Fukuda K., Sugihara A., Nakasho K., Tsujimura T., Yamada N., Okaya A., et al. The origin of biliary ductular cells that appear in the spleen after transplantation of hepatocytes. Cell Transplant 13 (2004) 27-33
22. Minguet S., Cortegano I., Gonzalo P., Martinez-Marin J.A., de Andres B., Salas C., et al. A population of c-kit (low) (CD45/TER119) hepatic cell progenitors of 11-day postcoitus mouse embryo liver reconstitutes cell-depleted liver organoids. J Clin Invest 112 (2003) 1152-1163
23. Taniguchi H., Kondo R., Suzuki A., Zheng Y.W., Takada Y., Fukunaga K., et al. Clonogenic colony-forming ability of flow cytometrically isolated hepatic progenitor cells in the murine fetal liver. Cell Transplant 9 (2000) 697-700
24. Wu X.Z., Zhao L.S., Xu Q., Zhang Y., and Tang H. Differentiation of bone marrow mesenchymal stem cells into hepatocytes in hepatectomized mouse. J Biomed Eng 22 (2005) 1234-1237
25. Collector M.I., Baylin S.B., Diehl A.M., and Sharkis S.J. Hematopoietic stem cells convert into liver cells within days without fusion. Nat Cell Biol 6 (2004) 532-539
26. Jiang Y., Jahagirdar B.N., Reinhardt R.L., Schwartz R.E., Keene C.D., Ortiz-Gonzalez X.R., et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418 (2002) 41-49
27. Fiegel H.C., Lioznov M.V., Cortes-Dericks L., Lange C., Kluth D., Fehse B., et al. Liver-specific gene expression in cultured human hematopoietic stem cells. Stem Cells 21 (2003) 98-104
28. Coussens L.M., and Werb Z. Inflammation and cancer. Nature 420 (2002) 860-867
29. Beachy P.A., Karhadkar S.S., and Berman D.M. Tissue repair and stem cell renewal in carcinogenesis. Nature 432 (2004) 324-331
30. Bissell D.M. Chronic liver injury, TGF-beta, and cancer. Exp Mol Med 33 (2001) 179-190
31. Ishikawa H., Nakao K., Matsumoto K., Nishimura D., Ichikawa T., Hamasaki K., et al. Bone marrow engraftment in a rodent model of chemical carcinogenesis but no role in the histogenesis of hepatocellular carcinoma. Gut 53 (2004) 884-889
32. Mason A., Wick M., White H., and Perrillo R. Hepatitis B virus replication in diverse cell types during chronic hepatitis B virus infection. Hepatology 18 (1993) 781-789
33. Bronowicki J.P., Loriot M.A., Thiers V., Grignon Y., Zignego A.L., and Brechot C. Hepatitis C virus persistence in human hematopoietic cells injected into SCID mice. Hepatology 28 (1998) 211-218
34. Yamada E., Montoya M., Schuettler C.G., Hickling T.P., Tarr A.W., Vitelli A., et al. Analysis of the binding of hepatitis C virus genotype 1a and 1b E2 glycoproteins to peripheral blood mononuclear cell subsets. J Gen Virol 86 (2005) 2507-2512
35. Okuda M., Hino K., Korenaga M., Yamaguchi Y., Katoh Y., and Okita K. Differences in hypervariable region 1 quasispecies of hepatitis C virus in human serum, peripheral blood mononuclear cells, and liver. Hepatology 29 (1999) 217-222
36. Lerat H., Rumin S., Habersetzer F., Berby F., Trabaud M.A., Trepo C., et al. In vivo tropism of hepatitis C virus genomic sequences in hematopoietic cells: influence of viral load, viral genotype, and cell phenotype. Blood 91 (1998) 3841-3849
37. Gabrielli A., Manzin A., Candela M., Caniglia M.L., Paolucci S., Danieli M.G., et al. Active hepatitis C virus infection in bone marrow and peripheral blood mononuclear cells from patients with mixed cryoglobulinaemia. Clin Exp Immunol 97 (1994) 87-93
38. Sansonno D., Lotesoriere C., Cornacchiulo V., Fanelli M., Gatti P., Iodice G., et al. Hepatitis C virus infection involves CD34(+) hematopoietic progenitor cells in hepatitis C virus chronic carriers. Blood 92 (1998) 3328-3337
39. Zignego A.L., Giannelli F., Marrocchi M.E., Mazzocca A., Ferri C., Giannini C., et al. T(14;18) translocation in chronic hepatitis C virus infection. Hepatology 31 (2000) 474-479
40. Galun E., Ilan Y., Livni N., Ketzinel M., Nahor O., Pizov G., et al. Hepatitis B virus infection associated with hematopoietic tumors. Am J Pathol 145 (1994) 1001-1007
41. Pontisso P., Locasciulli A., Schiavon E., Cattoretti G., Schiro R., Stenico D., et al. Detection of hepatitis B virus DNA sequences in bone marrow of children with leukemia. Cancer 59 (1987) 292-296
42. Sansonno D., De Vita S., Cornacchiulo V., Carbone A., Boiocchi M., and Dammacco F. Detection and distribution of hepatitis C virus-related proteins in lymph nodes of patients with type II mixed cryoglobulinemia and neoplastic or non-neoplastic lymphoproliferation. Blood 88 (1996) 4638-4645
43. Verhoef C., Pot R.G., de Man R.A., Zondervan P.E., Kuipers E.J., IJzermans J.N., et al. Detection of identical Helicobacter DNA in the stomach and in the non-cirrhotic liver of patients with hepatocellular carcinoma. Eur J Gastroenterol Hepatol 15 (2003) 1171-1174
44. Fan X.G., Peng X.N., Huang Y., Yakoob J., Wang Z.M., and Chen Y.P. Helicobacter species ribosomal DNA recovered from the liver tissue of chinese patients with primary hepatocellular carcinoma. Clin Infect Dis 35 (2002) 1555-1557
45. Fukuda K., Kuroki T., Tajima Y., Tsuneoka N., Kitajima T., Matsuzaki S., et al. Comparative analysis of Helicobacter DNAs and biliary pathology in patients with and without hepatobiliary cancer. Carcinogenesis 23 (2002) 1927-1931
46. Avenaud P., Marais A., Monteiro L., Le Bail B., Bioulac Sage P., Balabaud C., et al. Detection of Helicobacter species in the liver of patients with and without primary liver carcinoma. Cancer 89 (2000) 1431-1439
47. Nilsson H.O., Mulchandani R., Tranberg K.G., Stenram U., and Wadstrom T. Helicobacter species identified in liver from patients with cholangiocarcinoma and hepatocellular carcinoma. Gastroenterology 120 (2001) 323-324
48. Leone N., Pellicano R., Brunello F., Cutufia M.A., Berrutti M., Fagoonee S., et al. Helicobacter pylori seroprevalence in patients with cirrhosis of the liver and hepatocellular carcinoma. Cancer Detect Prev 27 (2003) 494-497
49. Huang Y., Fan X.G., Wang Z.M., Zhou J.H., Tian X.F., and Li N. Identification of Helicobacter species in human liver samples from patients with primary hepatocellular carcinoma. J Clin Pathol 57 (2004) 1273-1277
50. Pellicano R., Mazzaferro V., Grigioni W.F., Cutufia M.A., Fagoonee S., Silengo L., et al. Helicobacter species sequences in liver samples from patients with and without hepatocellularcarcinoma. World J Gastroenterol 10 (2004) 598-601
51. Ito K., Nakamura M., Toda G., Negishi M., Torii A., and Ohno T. Potential role of Helicobacter pylori in hepatocarcinogenesis. Int J Mol Med 13 (2004) 221-227
52. Ward J.M., Fox J.G., Anver M.R., Haines D.C., George C.V., Collins Jr. M.J., et al. Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel Helicobacter species. J Natl Cancer Inst 86 (1994) 1222-1227
53. Wu X.Z., and Chen D. Helicobacter pylori and hepatocellular carcinoma: correlated or uncorrelated?. J Gastrointerol Hepatol 21 (2006) 345-347
54. Kucia M., Reca R., Miekus K., Wanzeck J., Wojakowski W., Janowska-Wieczorek A., et al. Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis. Stem Cells 23 (2005) 879-894
55. Kucia M., Ratajczak J., Reca R., Janowska-Wieczorek A., and Ratajczak M.Z. Tissue-specific muscle, neural and liver stem/progenitor cells reside in the bone marrow, respond to an SDF-1 gradient and are mobilized into peripheral blood during stress and tissue injury. Blood Cells Mol Dis 32 (2004) 52-57
56. Hatch H.M., Zheng D., Jorgensen M.L., and Petersen B.E. SDF-1alpha/CXCR4: a mechanism for hepatic oval cell activation and bone marrow stem cell recruitment to the injured liver of rats. Cloning Stem Cells 4 (2002) 339-351
57. Heissig B., Ohki Y., Sato Y., Rafii S., Werb Z., and Hattori K. A role for niches in hematopoietic cell development. Hematology 10 (2005) 247-253
58. Martin M.A., and Bhatia M. Analysis of the human fetal liver hematopoietic microenvironment. Stem Cells Dev 14 (2005) 493-504
59. Kotton D.N., Fabian A.J., and Mulligan R.C. A novel stem-cell population in adult liver with potent hematopoietic-reconstitution activity. Blood 106 (2005) 1574-1580
60. von Marschall Z., Cramer T., Hocker M., Finkenzeller G., Wiedenmann B., and Rosewicz S. Dual mechanism of vascular endothelial growth factor upregulation by hypoxia in human hepatocellular carcinoma. Gut 48 (2001) 87-96
61. Cejudo-Martin P., Morales-Ruiz M., Ros J., Navasa M., Fernandez-Varo G., Fuster J., et al. Hypoxia is an inducer of vasodilator agents in peritoneal macrophages of cirrhotic patients. Hepatology 36 (2002) 1172-1179
62. Corpechot C., Barbu V., Wendum D., Kinnman N., Rey C., Poupon R., et al. Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis. Hepatology 35 (2002) 1010-1021
63. Larrivee B., Lane D.R., Pollet I., Olive P.L., Humphries R.K., and Karsan A. Vascular endothelial growth factor receptor-2 induces survival of hematopoietic progenitor cells. J Biol Chem 278 (2003) 22006-22013
64. Hattori K., Heissig B., Wu Y., Dias S., Tejada R., Ferris B., et al. Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment. Nat Med 8 (2002) 841-849
65. Gerber H.P., Malik A.K., Solar G.P., Sherman D., Liang X.H., Meng G., et al. VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism. Nature 417 (2002) 954-958
66. Hiratsuka S., Kataoka Y., Nakao K., Nakamura K., Morikawa S., Tanaka S., et al. Vascular endothelial growth factor A (VEGF-A) is involved in guidance of VEGF receptor-positive cells to the anterior portion of early embryos. Mol Cell Biol 25 (2005) 355-363
67. LeCouter J., Zlot C., Tejada M., Peale F., and Ferrara N. Bv8 and endocrine gland-derived vascular endothelial growth factor stimulate hematopoiesis and hematopoietic cell mobilization. Proc Natl Acad Sci USA 101 (2004) 16813-16818
68. Gerber H.P., and Ferrara N. The role of VEGF in normal and neoplastic hematopoiesis. J Mol Med 81 (2003) 20-31
69. De Silvestro G., Vicarioto M., Donadel C., Menegazzo M., Marson P., and Corsini A. Mobilization of peripheral blood hematopoietic stem cells following liver resection surgery. Hepatogastroenterology 51 (2004) 805-810
70. Hayashi Y., Wang W., Ninomiya T., Nagano H., Ohta K., and Itoh H. Liver enriched transcription factors and differentiation of hepatocellular carcinoma. J Clin Pathol: Mol Pathol 52 (1999) 19-24
71. Sugimoto S., Mitaka T., Ikeda S., Harada K., Ikai I., Yamaoka Y., et al. Morphological changes induced by extracellular matrix are correlated with maturation of rat small hepatocytes. J Cell Biochem 87 (2002) 16-28
72. Nagaki M., Shidoji Y., Yamada Y., Sugiyama A., Tanaka M., Akaike T., et al. Regulation of hepatic genes and liver transcription factors in rat hepatocytes by extracellular matrix. Biochem Biophys Res Commun 210 (1995) 38-43
73. Brill S., Zvibel I., Halpern Z., and Oren R. The role of fetal and adult hepatocyte extracellular matrix in the regulation of tissue-specific gene expression in fetal and adult hepatocytes. Eur J Cell Biol 81 (2002) 43-50
74. Nagaki M., Shidoji Y., Yamada Y., Sugiyama A., Tanaka M., Akaike T., et al. Regulation of hepatic genes and liver transcription factors in rat hepatocytes by extracellular matrix. Biochem Biophys Res Commun 210 (1995) 38-43
75. Brill S., Zvibel I., Halpern Z., and Oren R. The role of fetal and adult hepatocyte extracellular matrix in the regulation of tissue-specific gene expression in fetal and adult hepatocytes. Eur J Cell Biol 81 (2002) 43-50
76. Sidhu J.S., Liu F., and Omiecinski C.J. Phenobarbital responsiveness as a uniquely sensitive indicator of hepatocyte differentiation status: requirement of dexamethasone and extracellular matrix in establishing the functional integrity of cultured primary rat hepatocytes. Exp Cell Res 292 (2004) 252-264
77. Rana B., Mischoulon D., Xie Y., Bucher N.L., and Farmer S.R. Cell-extracellular matrix interactions can regulate the switch between growth and differentiation in rat hepatocytes: reciprocal expression of C/EBP alpha and immediate-early growth response transcription factors. Mol Cell Biol 14 (1994) 5858-5869
78. Shachaf C.M., Kopelman A.M., Arvanitis C., Karlsson A., Beer S., Mandl S., et al. MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer. Nature 431 (2004) 1112-1117
79. Mazure N.M., Nguyen T.L., and Danan J.L. Severe hypoxia specifically downregulates hepatocyte nuclear factor-4 gene expression in HepG2 human hepatoma cells. Tumour Biol 22 (2001) 310-317
80. Yamamoto T., Uenishi T., Ogawa M., Ichikawa T., Hai S., Sakabe K., et al. Immunohistologic attempt to find carcinogenesis from hepatic progenitor cell in hepatocellular carcinoma. Dig Surg 22 (2005) 364-370
81. Gabrilove J.L., Welte K., Lu L., Castro-Malaspina H., and Moore M.A. Constitutive production of leukemia differentiation, colony-stimulating, erythroid burst-promoting, and pluripoietic factors by a human hepatoma cell line: characterization of the leukemia differentiation factor. Blood 66 (1985) 407-415
82. Wang S.Y., Chen L.Y., Tsai T.F., Su T.S., Choo K.B., and Ho C.K. Constitutive production of colony-stimulating factors by human hepatoma cell lines: possible correlation with cell differentiation. Exp Hematol 24 (1996) 437-444
83. Sell S. Cellular origin of cancer: dedifferentiation or stem cell maturation arrest?. Environ Health Perspect 101 (1993) 15-26
84. Robrechts C., De Vos R., Van den Heuvel M., Van Cutsem E., Van Damme B., Desmet V., et al. Primary liver tumour of intermediate (hepatocyte-bile duct cell) phenotype: a progenitor cell tumour. Liver 18 (1998) 288-293
85. Theise N.D., Yao J.L., Harada K., Hytiroglou P., Portmann B., Thung S.N., et al. Hepatic 'stem cell' malignancies in adults: four cases. Histopathology 43 (2003) 263-271
86. Kim H., Park C., Han K.H., Choi J., Kim Y.B., Kim J.K., et al. Primary liver carcinoma of intermediate (hepatocyte-cholangiocyte) phenotype. J Hepatol 40 (2004) 298-304
87. Sell S. Cellular origin of hepatocellular carcinomas. Semin Cell Dev Biol 13 (2002) 419-424
88. Guettier C. Which stem cells for adult liver?. Ann Pathol 25 (2005) 33-44
89. Alison M.R., and Lovell M.J. Liver cancer: the role of stem cells. Cell Prolif 38 (2005) 407-421
90. Gournay J., Auvigne I., Pichard V., Ligeza C., Bralet M.P., and Ferry N. In vivo cell lineage analysis during chemical hepatocarcinogenesis in rats using retroviral-mediated gene transfer: evidence for dedifferentiation of mature hepatocytes. Lab Invest 82 (2002) 781-788
91. Wu X.Z., and Chen D. Origin of hepatocellular carcinoma: role of stem cells. J Gastroenterol Hepatol 21 (2006) 1093-1098
92. Wu X.Z., Chen D., and Xie G.R. Extracellular matrix remodeling in hepatocellular carcinoma: effects of soil on seed?. Med Hypotheses 66 (2006) 1115-1120
93. Fujii M., Yamashita Y., Shirabe K., Ijima H., Nakazawa K., Funatsu K., et al. Basic study about the development of the hybrid-artificial liver support system using human hepatoma cell lines (Hep G2, Huh 7): effects on liver functions by extracellular matrix (type I collagen) in monolayer culture. Fukuoka Igaku Zasshi 92 (2001) 299-305
94. Zhao M., Laissue J.A., and Zimmermann A. Tenascin and type IV collagen expression in liver cell dysplasia and in hepatocellular carcinoma. Histol Histopathol 11 (1996) 323-333
95. Kudriavtseva E.I., Morozova O.V., Rudinskaia T.D., and Engel'gard N.V. Disruption of intercellular contacts and cell-extracellular matrix interaction in rapidly growing murine hepatocarcinoma. Arkh Patol 63 (2001) 33-37
96. McCaughan G.W., Siah C.L., Abbott C., Wickson J., Ballesteros M., and Bishop G.A. Dipeptidyl peptidase IV is down-regulated in rat hepatoma cells at the mRNA level. J Gastroenterol Hepatol 8 (1993) 142-145
97. Caron J.M. Induction of albumin gene transcription in hepatocytes by extracellular matrix proteins. Mol Cell Biol 10 (1990) 1239-1243
98. Jaskiewicz K., Chasen M.R., and Robson S.C. Differential expression of extracellular matrix proteins and integrins in hepatocellular carcinoma and chronic liver disease. Anticancer Res 13 (1993) 2229-2237
99. Seebacher T., Medina J.L., and Bade E.G. Laminin alpha 5, a major transcript of normal and malignant rat liver epithelial cells, is differentially expressed in developing and adult liver. Exp Cell Res 237 (1997) 70-76
100. Torimura T., Ueno T., Inuzuka S., Kin M., Ohira H., Kimura Y., et al. The extracellular matrix in hepatocellular carcinoma shows different localization patterns depending on the differentiation and the histological pattern of tumors: immunohistochemical analysis. J Hepatol 21 (1994) 37-46
101. Yao M., Zhou X.D., Zha X.L., Shi D.R., Fu J., He J.Y., et al. Expression of the integrin alpha5 subunit and its mediated cell adhesion in hepatocellular carcinoma. J Cancer Res Clin Oncol 123 (1997) 435-440
102. Neuberger J. Liver transplantation. J Hepatol 1 (2000) 198-207
103. Ohashi K., Park F., and Kay M.A. Hepatocyte transplantation: clinical and experimental application. J Mol Med 79 (2001) 617-630
104. Lagasse E., Connors H., Al-Dhalimy M., Reitsma M., Dohse M., Osborne L., et al. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med 6 (2000) 1229-1234
105. Jones R.J., Matsui W.H., and Smith B.D. Cancer stem cells: are we missing the target?. J Natl Cancer I 96 (2004) 583-585